Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $3.28 Million - $5.9 Million
-79,410 Reduced 85.43%
13,539 $572,000
Q1 2024

May 15, 2024

SELL
$56.27 - $73.77 $12.7 Million - $16.7 Million
-226,130 Reduced 70.87%
92,949 $6.42 Million
Q4 2023

Feb 14, 2024

SELL
$59.06 - $75.72 $5.31 Million - $6.81 Million
-89,877 Reduced 21.98%
319,079 $23.6 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $5.81 Million - $8.73 Million
88,158 Added 27.48%
408,956 $27.9 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $14.6 Million - $22.2 Million
233,601 Added 267.9%
320,798 $30.1 Million
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $9.86 Million - $14.8 Million
-209,030 Reduced 70.56%
87,197 $5.91 Million
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $4.22 Million - $7.39 Million
139,086 Added 88.51%
296,227 $14.7 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $4.68 Million - $7.23 Million
146,351 Added 1356.36%
157,141 $5.11 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $384,231 - $822,521
10,790 New
10,790 $425,000
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $646,859 - $927,584
-11,238 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $2.86 Million - $3.97 Million
-39,419 Reduced 77.82%
11,238 $875,000
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $1.98 Million - $2.73 Million
21,992 Added 76.72%
50,657 $4.84 Million
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $2.51 Million - $3.73 Million
26,807 Added 1442.79%
28,665 $3.56 Million
Q1 2021

May 17, 2021

SELL
$116.57 - $155.01 $2.08 Million - $2.76 Million
-17,801 Reduced 90.55%
1,858 $245,000
Q4 2020

Feb 16, 2021

SELL
$99.61 - $142.12 $485,499 - $692,692
-4,874 Reduced 19.87%
19,659 $2.61 Million
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $1.74 Million - $2.44 Million
-23,895 Reduced 49.34%
24,533 $2.5 Million
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $2.45 Million - $4.07 Million
43,875 Added 963.65%
48,428 $4.21 Million
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $71,289 - $196,451
1,881 Added 70.4%
4,553 $264,000
Q4 2019

Feb 18, 2020

BUY
$77.66 - $99.74 $207,507 - $266,505
2,672 New
2,672 $247,000
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $1.9 Million - $2.51 Million
-21,257 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $817,268 - $1.27 Million
13,186 Added 163.38%
21,257 $1.84 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $64,614 - $95,306
-1,153 Reduced 12.5%
8,071 $509,000
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $445,426 - $743,454
9,224 New
9,224 $728,000
Q2 2018

Aug 14, 2018

SELL
$37.84 - $69.96 $413,704 - $764,872
-10,933 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $435,352 - $628,975
10,933 New
10,933 $441,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.